Production Cuts and Factory Shutdowns Due to COVID-19
First written in FY2020. 2 of 14 entries say "Worsened", first in FY2021-Q1. Latest entry: FY2026.
6 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「If infections including COVID-19, influenza and norovirus spread among the Group’s employees, the Group’s business and other activities could be affected, including through temporary suspension of operations. Similarly, if infections spread among business partners, the Group’s business and other activities could be affected by suspension of operations by those business partners.」
We continue to assess the risk of production stoppages resulting from infectious diseases in general, including influenza and norovirus, in addition to COVID-19. - FY2024RestatedAnnual report
「If infections including COVID-19, influenza and norovirus spread among the Group’s employees, the Group’s business and other activities could be affected, including through temporary suspension of operations. Similarly, if infections spread among business partners, the Group’s business and other activities could be affected by suspension of operations by those business partners.」
We continue to assess the risk of production stoppages resulting from infectious diseases in general, including influenza and norovirus, in addition to COVID-19. - FY2024-Q1MitigatedAnnual report
「Although the business environment surrounding the Group was on a recovery track as restrictions on movement related to COVID-19 were eased, the outlook remained uncertain owing to persistently high raw-material and energy costs, rising labor and logistics costs, the prolonged situation in Ukraine, sharp exchange-rate fluctuations and other factors」
The company described easing restrictions on activities due to COVID-19 and a recovery trend in the business environment, indicating that the impact of the broad activity restrictions caused by the pandemic had eased in part. However, uncertainty over the outlook continued. - FY2023ReframedAnnual report
「If infections including COVID-19, influenza and norovirus spread among the Group’s employees, the Group’s business and other activities could be affected, including through temporary suspension of operations. Similarly, if infections spread among business partners, the Group’s business and other activities could be affected by suspension of operations by those business partners.」
The previous theme of production cuts and plant shutdowns due to COVID-19 has been reframed as the broader risk of infectious diseases, including influenza and norovirus. - FY2023-Q2MitigatedAnnual report
「North America and other regions) Revenue, excluding intersegment revenue, was ¥3,184 million, up 35.4% year on year, as the business recovered from the effects of COVID-19 in the same period of the previous year and benefited from foreign exchange effects resulting from the weaker yen, despite the impact of customer production adjustments and other factors caused by the prolonged semiconductor shortage.」
The company stated that the North America and other segment had recovered from the effects of COVID-19 seen in the same period of the previous year. However, production adjustments due to the semiconductor shortage continued. - FY2022WorsenedAnnual report
「The automotive industry, in which the Group operates, also faced increasing uncertainty over the outlook as production adjustments and other measures occurred successively worldwide due to the impact of COVID-19 and the prolonged semiconductor supply shortage.」
While describing a recovery trend from the effects of the pandemic, the company stated that uncertainty over the outlook had increased as global production adjustments occurred successively due to the prolonged pandemic and semiconductor shortage. - FY2022-Q3Continued production adjustments amid recoveryAnnual report
「The automotive industry, in which the Group operates, also faced an uncertain outlook as production adjustments and other measures occurred successively worldwide due to the impact of COVID-19 and the prolonged semiconductor supply shortage.」
While describing an economic recovery trend centered on developed countries, the company stated that production adjustments were occurring successively worldwide due to the continuing impact of the pandemic and the prolonged semiconductor supply shortage. - FY2022-Q2Continued production adjustments amid recoveryAnnual report
「Although economic activity had stagnated due to the global spread of COVID-19, it was recovering gradually, particularly in developed countries, as vaccinations expanded. However, the outlook remains uncertain due to differences in vaccination rates among countries and the global semiconductor shortage.」
While describing a gradual recovery trend, particularly in developed countries, the company stated that uncertainty over the outlook continued due to differences in vaccination rates among countries and the semiconductor supply shortage. - FY2022-Q1Continuing uncertainty amid recovery due to the pandemic and supply shortagesAnnual report
「Although economic activity had stagnated owing to the global spread of COVID-19, the economy was on a gradual recovery track, partly owing to the start of vaccination programs. However, the outlook remained uncertain owing to differences in vaccination progress between countries, the emergence of COVID-19 variants and the global semiconductor supply shortage.」
While describing a gradual recovery resulting from the start of vaccinations and other factors, the company stated that uncertainty over the outlook continued due to differences in vaccination progress, variants and the semiconductor supply shortage. - FY2021Recovery trend and continuing pandemic effectsAnnual report
「Although economic activity had stagnated due to the global spread of COVID-19, it was beginning to recover gradually as a result of government economic support measures and the start of vaccinations. However, the outlook remains uncertain due to the emergence of COVID-19 variants and the global semiconductor shortage.」
The company described a recovery trend resulting from government support and vaccinations, while the effects of the pandemic and uncertainty over the outlook continued due to the emergence of variants and the semiconductor shortage. - FY2021-Q3Progress in recovery and continuing pandemic effectsAnnual report
「Although global sales and production volumes in the automotive industry, in which the Group operates, had declined substantially, they were showing a solid recovery in the third quarter.」
Global automotive sales and production volumes were said to be showing a solid recovery in the third quarter. However, cumulative revenue was down 23.0% year on year due to the impact of the pandemic, and losses in North America and other segments also widened, indicating that the effects were continuing. - FY2021-Q2Regional recovery trends and continuing pandemic effectsAnnual report
「The business environment surrounding the Group remains challenging due to continued restrictions on economic activity and travel resulting from the global spread of COVID-19.」
While restrictions on economic activity and travel due to the pandemic continued, customer production in Japan and the Chinese market began to recover from the second quarter. Cumulative revenue was down 34.0% year on year, and the operating loss was ¥1,456 million. - FY2021-Q1WorsenedAnnual report
「The business environment surrounding the Group became extremely challenging due to the impact of restrictions on economic activity and travel resulting from the global spread of COVID-19. Although economic activity has recently begun to resume, the outlook remains highly uncertain and difficult, as no fundamental measures to address COVID-19 are yet in place. Against this backdrop, revenue for the cumulative first quarter of the current consolidated fiscal year was ¥12,582 million, down 37.0% year on year, due to the impact of lower global customer production volumes resulting from COVID-19.」
The risk from the pandemic became more pronounced and concrete than in the previous fiscal year through global restrictions on economic activity and travel, including a 37.0% year-on-year decline in revenue due to lower production volumes at global customers and an operating loss of ¥1,214 million. - FY2020First statedAnnual report
「Due to production cuts by business partners accompanying the spread of COVID-19, the Group has temporarily suspended operations at some of its overseas and domestic plants.」
The company disclosed infection risk separately for the first time, stating that production cuts by business partners and temporary shutdowns at some plants had actually occurred as a result of the spread of COVID-19.